Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter Baumannii with aerosolized colistin in neonates: A preliminary report

2010 ◽  
Vol 46 (1) ◽  
pp. 60-66 ◽  
Author(s):  
Narongsak Nakwan ◽  
Jeerawan Wannaro ◽  
Tipaporn Thongmak ◽  
Pornpat Pornladnum ◽  
Ratchanee Saksawad ◽  
...  
Keyword(s):  
Acinetobacter Baumannii ◽  
Preliminary Report ◽  
Ventilator Associated Pneumonia ◽  
Drug Resistant

scholarly journals Tigecycline combination for ventilator-associated pneumonia caused by extensive drug-resistant Acinetobacter baumannii

2016 ◽  
Vol 8 (10) ◽  
pp. 2784-2792 ◽  
Author(s):  
Hangyong He ◽  
Yali Zheng ◽  
Bing Sun ◽  
Xiao Tang ◽  
Rui Wang ◽  
...  
Keyword(s):  
Acinetobacter Baumannii ◽  
Ventilator Associated Pneumonia ◽  
Drug Resistant

Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: Risk factors, clinical features, and outcomes

2014 ◽  
Vol 42 (2) ◽  
pp. 206-208 ◽  
Author(s):  
Eylem Sercan Özgür ◽  
Elif Sahin Horasan ◽  
Kerem Karaca ◽  
Gülden Ersöz ◽  
Sibel Naycı Atış ◽  
...  
Keyword(s):  
Risk Factors ◽  
Acinetobacter Baumannii ◽  
Clinical Features ◽  
Ventilator Associated Pneumonia ◽  
Drug Resistant

scholarly journals Ventilator-Associated Pneumonia due to Drug-Resistant Acinetobacter baumannii: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality

Medicina ◽  
2019 ◽  
Vol 55 (2) ◽  
pp. 49 ◽  
Author(s):  
Aušra Čiginskienė ◽  
Asta Dambrauskienė ◽  
Jordi Rello ◽  
Dalia Adukauskienė
Keyword(s):  
Risk Factors ◽  
Hospital Mortality ◽  
Acinetobacter Baumannii ◽  
Sofa Score ◽  
Female Gender ◽  
Ventilator Associated Pneumonia ◽  
Drug Resistant ◽  
Resistance Profile ◽  
Saps Ii ◽  
Rbc Transfusion

: Background and objectives: High mortality and healthcare costs area associated with ventilator-associated pneumonia (VAP) due to Acinetobacter baumannii (A.baumannii). The data concerning the link between multidrug-resistance of A.baumannii strains and outcomes remains controversial. Therefore, we aimed to identify the relation of risk factors for ventilator-associated pneumonia (VAP) and mortality with the drug resistance profiles of Acinetobacter baumannii (A.baumannii) and independent predictors of in-hospital mortality. Methods: A retrospective ongoing cohort study of 60 patients that were treated for VAP due to drug-resistant A.baumannii in medical-surgical intensive care units (ICU) over a two-year period was conducted. Results: The proportions of multidrug-resistant (MDR), extensively drug-resistant (XDR), and potentially pandrug-resistant (pPDR) A.baumannii were 13.3%, 68.3%, and 18.3%, respectively. The SAPS II scores on ICU admission were 42.6, 48.7, and 49 (p = 0.048); hospital length of stay (LOS) prior to ICU was 0, one, and two days (p = 0.036), prior to mechanical ventilation (MV)—0, 0, and three days (p = 0.013), and carbapenem use prior to VAP—50%, 29.3%, and 18.2% (p = 0.036), respectively. The overall in-hospital mortality rate was 63.3%. In MDR, XDR, and pPDR A.baumannii VAP groups, it was 62.5%, 61.3%, and 72.7% (p = 0.772), respectively. Binary logistic regression analysis showed that female gender (95% OR 5.26; CI: 1.21–22.83), SOFA score on ICU admission (95% OR 1.28; CI: 1.06–1.53), and RBC transfusion (95% OR 5.98; CI: 1.41–25.27) were all independent predictors of in-hospital mortality. Conclusions: The VAP risk factors: higher SAPS II score, increased hospital LOS prior to ICU, and MV were related to the higher resistance profile of A.baumannii. Carbapenem use was found to be associated with the risk of MDR A.baumannii VAP. Mortality due to drug-resistant A.baumannii VAP was high, but it was not associated with the A.baumannii resistance profile. Female gender, SOFA score, and RBC transfusion were found to be independent predictors of in-hospital mortality.

Sign in / Sign up

Export Citation Format

Share Document